Severity of COVID-19 in patients with lung cancer: evidence and challenges

Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts with the healthcare system, immunocompromised state from cancer or its therapies, supportive medications such as steroids and most importantly their advanced age and comorbidities. Patients with lung cancer have...

Descripción completa

Detalles Bibliográficos
Autores principales: Passaro, Antonio, Bestvina, Christine, Velez Velez, Maria, Garassino, Marina Chiara, Garon, Edward, Peters, Solange
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978268/
https://www.ncbi.nlm.nih.gov/pubmed/33737345
http://dx.doi.org/10.1136/jitc-2020-002266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978268/
https://www.ncbi.nlm.nih.gov/pubmed/33737345
http://dx.doi.org/10.1136/jitc-2020-002266

Ejemplares similares